Publications by authors named "Stacy Moulder"

110Publications

Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma.

Hum Pathol 2020 Nov 19;108:42-50. Epub 2020 Nov 19.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States. Electronic address:

View Article and Find Full Text PDF
November 2020

A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations.

Breast Cancer Res 2020 11 4;22(1):121. Epub 2020 Nov 4.

Houston Methodist Research Institute, 6670 Bertner Ave, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
November 2020

A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.

Invest New Drugs 2020 Sep 28. Epub 2020 Sep 28.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building CPB5.3542, 1515 Holcombe Blvd. Unit 1354, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
September 2020

Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients.

Eur J Radiol 2020 Sep 10;130:109170. Epub 2020 Jul 10.

Breast Imaging Department, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article and Find Full Text PDF
September 2020

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

JAMA Oncol 2020 Sep;6(9):1355-1362

Berry Consultants, LLC, Austin, Texas.

View Article and Find Full Text PDF
September 2020

Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer.

Am J Cancer Res 2020 1;10(2):648-661. Epub 2020 Feb 1.

Graduate Institute of Biomedical Sciences, Research Center for Cancer Biology, Center for Molecular Medicine, China Medical University Taichung 404, Taiwan.

View Article and Find Full Text PDF
February 2020

Debating the Optimal Approach to Nodal Management After Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:42-48. Epub 2019 May 17.

7 Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI.

View Article and Find Full Text PDF
January 2019

Imaging features of triple-negative breast cancers according to androgen receptor status.

Eur J Radiol 2019 May 21;114:167-174. Epub 2019 Mar 21.

Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address:

View Article and Find Full Text PDF
May 2019